Analyst firms · Citigroup · CE
Citigroup CE price target and rating history
Celanese Corporation (CE) · Industrials
Citigroup rates Celanese Corporation (CE) Buy with a $53 price target, as of its latest action on Oct 2, 2025. It has published 5 rating actions on CE since July 2021, including 1 upgrade and 1 downgrade. Across 6 firms with a CE price target in the last 12 months, the median target is $58.50.
- Current rating
- Buy
- Price target
- $53
- Median target, all firms
- $58.50
- Actions on CE
- 5
Citigroup price target on CE
Every Citigroup rating on CE
- Oct 2, 2025
- Jun 14, 2023
- Aug 1, 2022
- Oct 25, 2021
- Jul 26, 2021
How other firms rate CE
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Barclays | Equal Weight | $49 | Oct 13, 2026 |
| KeyBanc Capital Markets | Overweight | $57 | Sep 11, 2026 |
| Wells Fargo | Overweight | $70 | Mar 13, 2026 |
| Vertical Research | Buy | $60 | Mar 9, 2026 |
| Tudor, Pickering, Holt & Co. | Buy | Mar 9, 2026 | |
| Jefferies | Buy | $86 | Feb 5, 2026 |
| Morgan Stanley | Equal-Weight | $50 | Jan 20, 2026 |
Questions about Citigroup and CE
- What is Citigroup's price target for CE?
- Citigroup's latest stated price target for Celanese Corporation (CE) is $53, from its action on Oct 2, 2025.
- What is Citigroup's rating on CE?
- Citigroup rates CE Buy, a bullish rating, as of Oct 2, 2025.
- When did Citigroup last change its view on CE?
- On Oct 2, 2025, Citigroup upgrades to Buy from Neutral, price target $53.
- How does Citigroup's CE target compare with other analysts?
- Across 6 firms with a CE price target in the last 12 months, the median target is $58.50.
More CE rating histories
- Barclays3
- KeyBanc Capital Markets6
- Wells Fargo8
- Vertical Research5
- BMO Capital Markets4
- RBC Capital Markets5
- BofA Securities4
- Piper Sandler9
- Deutsche Bank5
- J.P. Morgan3
All Citigroup ratingsCE news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.